💬 Viewpoint: Medical education should shift from pattern recognition to critical thinking and pathophysiological reasoning to reduce diagnostic errors and adapt to #AI advancements. #MedEd ja.ma/46VhjuI

Looking forward to reading this one.

Important, evidence-based information about birth control pills.

Epigenetic Modifiers in Cancer Therapy: Unlocking New Treatment Pathways oncodaily.com/oncolibrary/... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #EpigeneticModifiers #CancerTherapy

Our inflammatory breast cancer program is raising money to help patients manage out of pocket costs on trials and to find new targets. Every dollar goes to the research. Please help if you can! mdanderson.donordrive.com/participants...

'In this review we discuss recent technological advancements and how their application to T cells has the potential to steer the next generation of cellular therapy. We highlight emerging applications and current technological limitations that future tool development aims to overcome.'

Done. Nobody who is metastatic should have to wait months for disability benefits they’ve paid into or years to be eligible for Medicare coverage.

When it feels like you’re drowning in intake forms, visit notes, bills and patient education documents, it can be hard to know where to start with organization. MD Anderson leadership practitioner Janice Simon shares expert tips: spr.ly/63328fxWTe #OncSky #EndCancer

"Society treats illness as a series of discrete medical events while ignorng the psychological aftermath tht often follows. Whether someone is living w/ #cancer, #MS, ulcerative colitis, #longCovid or anothr autoimmune or chronic illness, the emotional reverberations — marked ..." 1/2 #CanSky #IDSky

You’re welcome. I just wanted to alert other women - and the men who love them - as many friends had no idea that purple breasts could indicate IBC or even that inflammatory breast cancer is out there as a different and dangerous form.

An IBC-specific biomarker would be huge. Thanks to all scientists and clinicians who do life-saving work focused on inflammatory breast cancer. #thinkIBC

“The shooting was “just the perfect, terrible metaphor for what public health has endured these past six months — and the past six years,” said Katelyn Jetelina, a public health expert who has worked closely with the C.D.C.”

For more than a century, NIH-sponsored research has played a critical role in improving the nation’s health. This vital work must continue.

This comes up a lot when I talk with other epidemiologists. The detention centers are perfect launchpads for disease outbreaks. Republicans won’t care because they don’t see the migrants as human. But they should remember that infectious disease won’t stop at the walls of the detention center.

Thanks to you and to everyone on the committee for your hard work. A lot of work remains - educating doctors about IBC; getting more IBC-specific research - but this is a great start, especially for getting much-needed data. #thinkibc

Filipa Lynce, MD, FASCO, received the Advanced Clinical Research Award in Breast Cancer Research from Conquer Cancer, the @ascocancer.bsky.social Foundation. Lynce's work will focus on deciphering mechanisms of response to novel therapies in HER2 expressing stage III Inflammatory Breast Cancer.

When Ethan's family needed a miracle, Medicaid allowed them to "choose life" for him. This Sat, July 26, let's stand up for the millions of families in America, like Ethan's, who deserve compassion and care, not cruelty! 📌 Find an event near you: www.mobilize.us/familiesfirs... #FamiliesFirst

Exactly

Important read.

Data suggests another summer of illness could be in the offing as people get more out of date with vaccination.

Deadly

Key alternatives for those who have had hormone-positive breast cancer.

Dendritic copolymer-drug conjugates dramatically improved triple-negative breast cancer treatment, achieving 95% tumor suppression with reduced side effects. by Liu G, Wang B (...) Luo K et 4 al. in Acta Biomater #MedSky 👉 get more here 📖 read the article:

Important research on IBC that can also benefit understanding other types of aggressive #breastcancer

Every major health system in Louisiana is warning Speaker Mike Johnson and the rest of the state’s congressional delegation that the Senate GOP’s planned Medicaid cuts “would be historic in their devastation.”

“Who decides who decides?” Partnered w/ @shrutipatelmd.bsky.social on this editorial from Dr. Campbell & @laurabukavinamd.bsky.social work in which we explore how altmetrics & digital clout are shaped by systemic bias #MedSky #WomenInMedicine ascopubs.org/doi/10.1200/...

Dr. Katelyn Jetelina @kkjetelina.bsky.social and I will host live analysis following Thursday’s ACIP session at 1pm ET on Substack. Details soon (subscribe to our Substacks for free to get notified).

Editor’s choice from this week's issue of #JAMA: ➡️ Modeling Reemergence of Vaccine-Eliminated Infectious Diseases ➡️ A Multidimensional Diagnostic Approach for COPD ➡️ The Microbiome and Cancer; and more. ja.ma/4eRp9GH

No excuses here. AT ALL. #Medsky www.nbcnews.com/nightly-news...

Good to know SERDs are there as an alternative, since AIs are intolerable for some.

"If biomedical research remains as imp't in the future as in the past, a 15.3% reduction in new therapies wld lead 2 a reduction in life expectancy of 0.24 yrs per person over the next 25 yrs. In a populatn of more than 340M, this reflects 82M fewer yrs of life. Economists ... " 1/2 #CanSky #OncoSky

OS and QoL should be the only measures in clinical research trials. Without those, DFS or PFS are simply false hope.

DESTINY-Breast06 Trial Updates at ESMO Breast 2025 Confirms T-DXd Efficacy in HER2-Low and Ultralow mBC @myesmo.bsky.social @eliasegui.bsky.social oncodaily.com/oncolibrary/... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #DESTINY-Breast06 #ESMOBreast25 #BreastCancer

Today in Congress, HHS Sec RFK Jr insisted that "We are not withholding money for lifesaving research." The @nytimes.com described the interaction as a "clash". Yes, between facts and talking points. Fact: HHS is withholding money for lifesaving research. www.nytimes.com/2025/05/14/u...

Pharmacy closures = reduced access Rite Aid, Walgreens & others are shutting down 2,200+ stores in 2025. Even if you’re insured, no nearby pharmacy means meds, vaccines, and care may be out of reach. the-sun.com/money/14180873/rite-aid-walgreens-pharmacies-closing-health 🏥🚫💊

Absolutely infuriating but sadly not surprising to many cancer patients.

Internal records show that the NIH axed grants for research about transgender people despite a court order barring the cuts. Agency officials also testified that DOGE was involved in directing grant terminations. By @anniewaldman.bsky.social

More awful news

“So, to recap here,” Porter said. “The drug didn’t get any better. The cancer patients didn’t get any better. You just got better at making money. You just refined your skills at price gouging.”

#nbcc2025 Proud to be at NBCC’s Rally & Lobby Day

Are you a health equity researcher who has lost federal funding for a project? RWJF’s Evidence for Action is offering Rapid Response grants to support community-centered, social science research disrupted by cuts. ☀️ More details: www.rwjf.org/en/grants/ac...

Paolo Tarantino: ADCs are rapidly moving to earlier line treatment for breast cancer @ptarantinomd.bsky.social oncodaily.com/blog/paolo-t... #OncoDaily #Oncology #Cancer #Health #Medicine #MedEd #MedOnc #MedNews #ADCs #BreastCancer

"The contract terminatns 4 its 4 main sites 'will signf'ly impact ongoing research & data collectn … severely limit[ing] WHI’s ability 2 generate new insghts into the health of older womn, 1 of the fastst-growing segmnts of our pop'n.” There are ~55M postmeno women in the US ... 1/2 #CanSky #MedSky

#nih Listening real time to Dr. Jay Bhattacharya share his vision for NIH during the public Council of Council meeting. It is a “sea change” If you receive NIH funding, this is a videocast to replay and watch. videocast.nih.gov/watch=56725

Your periodic reminder that you have the right to find out why your health insurer denied your claim. We built a tool to help you do it: projects.propublica.org/claimfile/

But only in those who have residual disease, apparently. For those, it made a difference with folks as low as 5% ER+.

Sacituzumab tirumotecan significantly improved progression-free survival in pretreated metastatic triple-negative breast cancer compared to standard chemotherapy. by Yin Y, Fan Y (...) Xu B et 16 al. in Nat Med #MedSky 👉 get more here 📖 read the article:

Exciting news for ER+ folks, including HER2-low and ultra-low (Enhertu)

Capiversatib (Truqap) nw available in much of the UK for HR+/HER-2 neg metastatic patients. www.theguardian.com/society/2025...

As health and environmental concerns about PFAs, or “forever chemicals,” mount nationally, states are beginning to legislate against them. Now, the chemical and consumer products industries are mounting a counterattack, deploying lawyers and lobbyists.